13F
← All fund report cards

Louisiana State Employees Retirement System

13F equity value
$5.7B
Positions
1,517
Top 10 concentration
27.5%
Quarters / total new picks
32 / 646
13F equity value over time
$0M$3B$6B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 43.8% of quarters (excess t = 0.13, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.4%
t-stat
0.13
Quarterly win rate
44%
Annualized excess
-1.4%
$1 → follow vs universe
$1.88 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.03320180630: follow 0.95020180930: follow 1.02720181231: follow 1.03120190331: follow 1.03620190630: follow 1.20420190930: follow 1.27920191231: follow 1.05120200331: follow 1.79120200630: follow 1.99020200930: follow 2.54520201231: follow 2.41920210331: follow 2.50720210630: follow 2.80720210930: follow 2.35420211231: follow 1.81720220331: follow 2.13320220630: follow 1.99620220930: follow 2.07020221231: follow 1.80120230331: follow 1.95320230630: follow 1.87520230930: follow 2.08320231231: follow 2.13120240331: follow 2.11120240630: follow 2.40420240930: follow 2.17620241231: follow 1.95420250331: follow 2.01920250630: follow 1.90620250930: follow 1.96420251231: follow 1.884 0.84 1.93 3.03 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1517 · 2026 Q1

Ticker Value Weight QoQ
NVDA $317M
5.5%
HOLD
AAPL $279M
4.9%
HOLD
MSFT $205M
3.6%
HOLD
AMZN $157M
2.8%
HOLD
GOOGL $125M
2.2%
HOLD
AVGO $110M
1.9%
HOLD
GOOG $105M
1.8%
HOLD
META $104M
1.8%
HOLD
TSLA $97M
1.7%
ADD
WMT $68M
1.2%
ADD
COST $52M
0.9%
HOLD
SPYM $51M
0.9%
ADD
NFLX $47M
0.8%
HOLD
BRK/B $45M
0.8%
HOLD
MU $44M
0.8%
HOLD
JPM $40M
0.7%
HOLD
PLTR $39M
0.7%
HOLD
AMD $39M
0.7%
HOLD
LLY $37M
0.7%
HOLD
XOM $36M
0.6%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.